Business Description
Microbio Co Ltd
ISIN : TW0004128004
Total Employee Number:
577Compare
Compare
Traded in other countries / regions
4128.Taiwan IPO Date
2006-06-09Description
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.95 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -1.01 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.92 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.2 | |||||
3-Year FCF Growth Rate | -45.5 | |||||
3-Year Book Growth Rate | -9.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.96 | |||||
9-Day RSI | 44.15 | |||||
14-Day RSI | 48.08 | |||||
3-1 Month Momentum % | -17.18 | |||||
6-1 Month Momentum % | -28.99 | |||||
12-1 Month Momentum % | -37.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.3 | |||||
Quick Ratio | 3.97 | |||||
Cash Ratio | 3.35 | |||||
Days Inventory | 70.21 | |||||
Days Sales Outstanding | 16.62 | |||||
Days Payable | 45.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.78 | |||||
Operating Margin % | -21.47 | |||||
Net Margin % | -40.01 | |||||
EBITDA Margin % | -35.12 | |||||
FCF Margin % | 0.85 | |||||
OCF Margin % | 4.5 | |||||
ROE % | -8.07 | |||||
ROA % | -5.9 | |||||
ROIC % | -4.05 | |||||
3-Year ROIIC % | 8.99 | |||||
ROC (Joel Greenblatt) % | -52.12 | |||||
ROCE % | -7.66 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.92 | |||||
PB Ratio | 1.04 | |||||
Price-to-Tangible-Book | 1.06 | |||||
Price-to-Free-Cash-Flow | 660.41 | |||||
Price-to-Operating-Cash-Flow | 112.42 | |||||
EV-to-EBIT | -9.18 | |||||
EV-to-EBITDA | -12.98 | |||||
EV-to-Revenue | 4.55 | |||||
EV-to-FCF | 585.44 | |||||
Price-to-GF-Value | 0.35 | |||||
Price-to-Projected-FCF | 1.2 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Earnings Yield (Greenblatt) % | -10.89 | |||||
FCF Yield % | 0.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Microbio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,894.112 | ||
| EPS (TTM) (NT$) | -1.29 | ||
| Beta | -0.7846 | ||
| 3-Year Sharpe Ratio | -1.67 | ||
| 3-Year Sortino Ratio | -1.69 | ||
| Volatility % | 26.46 | ||
| 14-Day RSI | 48.08 | ||
| 14-Day ATR (NT$) | 0.77208 | ||
| 20-Day SMA (NT$) | 16.175 | ||
| 12-1 Month Momentum % | -37.84 | ||
| 52-Week Range (NT$) | 14.2 - 27.5 | ||
| Shares Outstanding (Mil) | 588.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Microbio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Microbio Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.05:1 Stock Split | 2024-08-29 | 42.90 (+0.33%) | ||
| 1.09811:1 Stock Split | 2023-06-16 | 53.17 (-0.97%) | ||
| 1.096:1 Stock Split | 2022-07-18 | 43.52 (-0.18%) | ||
| 1.0982:1 Stock Split | 2021-09-28 | 42.95 (+2.41%) | ||
| 1.04015:1 Stock Split | 2013-08-27 | 21.28 (-2.78%) | ||
| 1.19:1 Stock Split | 2012-08-28 | 21.35 (-1.57%) | ||
| 1.2198:1 Stock Split | 2011-07-19 | 21.12 (+4.99%) |
Show
Entries
Microbio Co Ltd Frequently Asked Questions
What is Microbio Co Ltd(ROCO:4128)'s stock price today?
The current price of ROCO:4128 is NT$15.85. The 52 week high of ROCO:4128 is NT$27.50 and 52 week low is NT$14.20.
When is next earnings date of Microbio Co Ltd(ROCO:4128)?
The next earnings date of Microbio Co Ltd(ROCO:4128) is .
Does Microbio Co Ltd(ROCO:4128) pay dividends? If so, how much?
Microbio Co Ltd(ROCO:4128) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Microbio Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers